Medication non-adherence is when a patient does not take their prescribed medications as directed, whether by skipping doses, stopping early, taking the wrong amount, or never filling the prescription in the first place. It is far more common than most people realize. The World Health Organization estimates that only about 50% of patients with chronic diseases in developed countries take their medications as prescribed. In the United States alone, non-adherence is linked to roughly 125,000 deaths per year and at least 10% of hospitalizations in older adults.
Types of Non-Adherence
Non-adherence isn’t one behavior. It breaks down into distinct patterns, and understanding which type applies can point toward different solutions.
Primary non-adherence happens when a doctor writes a prescription but the patient never fills it at a pharmacy. The medication is prescribed, and the process stops right there. This is surprisingly common and often invisible to the prescribing doctor, who may assume the patient started treatment.
Secondary non-adherence is what most people picture: the patient fills the prescription but then doesn’t take the medication correctly. This includes skipping doses, taking less than prescribed, stopping the medication early because symptoms improved, or taking it at the wrong times.
Within both categories, there’s an important distinction between intentional and unintentional non-adherence. Unintentional non-adherence stems from practical barriers like cost, difficulty getting to a pharmacy, or simply forgetting. Intentional non-adherence is driven by a patient’s beliefs or emotional responses to medication, such as doubting whether the drug works, fearing side effects, or feeling that the condition isn’t serious enough to warrant treatment. Many people experience both at different times.
Why People Stop Taking Their Medications
The World Health Organization identifies five categories of barriers that interact with each other: patient-related factors, the healthcare system, the therapy itself, the condition being treated, and social and economic circumstances. In practice, these overlap constantly.
Cost is one of the most straightforward barriers. Even modest copays can deter people from refilling prescriptions, particularly when they’re managing multiple chronic conditions. Transportation and pharmacy access matter too. Research on Medicaid patients found that those with the lowest adherence rates were often the same people who lacked reliable access to a car for medical appointments and had limited internet access at home, making it harder to use mail-order pharmacies or digital tools.
Health literacy plays a quieter but significant role. People with more education tend to have higher health literacy, and higher health literacy correlates with better adherence. If you don’t fully understand why a medication matters or how to take it, you’re less likely to stick with it, especially when you feel fine. This is a particular challenge with conditions like high blood pressure or high cholesterol, where the disease causes no symptoms until serious damage is done.
Side effects and complex regimens create therapy-related barriers. The more pills someone takes per day, and the more unpleasant the side effects, the more likely they are to cut back or quit. Conditions that feel manageable without medication, or that fluctuate in severity, also make it tempting to skip doses during “good” stretches.
The Health and Financial Cost
Non-adherence costs the U.S. healthcare system between $100 billion and $290 billion annually. On an individual level, the economic burden varies widely by condition: disease-specific costs attributable to non-adherence range from roughly $949 to over $44,000 per person per year, depending on the illness. When all causes of non-adherence are combined, the per-person cost ranges from about $5,271 to $52,341 annually.
The clinical consequences are just as stark. Patients who consistently take their blood pressure medications are 30% to 45% more likely to achieve blood pressure control compared to those who don’t. That gap translates directly into fewer heart attacks, strokes, and kidney problems. Across all chronic conditions, non-adherence leads to faster disease progression, more emergency room visits, and higher rates of hospitalization and readmission.
How Adherence Is Measured
Healthcare systems and researchers use pharmacy refill records to estimate whether patients are taking their medications. Two common metrics are the Medication Possession Ratio (MPR) and the Proportion of Days Covered (PDC).
MPR adds up the total days’ supply of medication dispensed over a time period and divides it by the number of days in that period. It’s simple, but it has a flaw: if you refill your prescription early every time, your MPR gets inflated above 100%, making it look like you have more medication than you could possibly need.
PDC solves this by looking at which specific days you actually had medication available. If you refill early, the extra supply is shifted forward to start after your current supply runs out. This gives a more honest picture of coverage and can never exceed 100%. PDC is generally considered the more reliable measure and is the standard used by most quality reporting programs. A PDC of 80% or higher is typically the threshold for considering a patient “adherent,” though this varies by condition.
Neither metric can confirm whether someone actually swallowed their pills. They only confirm that medication was picked up from the pharmacy. Self-report surveys and pill counts are sometimes used alongside refill data, but each method has its own blind spots.
Strategies That Improve Adherence
The most effective interventions tend to be tailored to the individual rather than one-size-fits-all. The CDC’s Community Preventive Services Task Force recommends pharmacy-based interventions that combine several approaches, and has found them to be cost-effective for preventing cardiovascular disease specifically.
Practical tools are a starting point: pillboxes, medication calendars, and refill synchronization (where all your prescriptions are aligned to be picked up on the same day each month). The appointment-based model takes this further by assigning patients a specific day to pick up all medications, which also helps the pharmacy anticipate and prepare orders in advance.
Counseling and motivational interviewing, where a pharmacist talks through a patient’s concerns and goals rather than simply instructing them, address the intentional side of non-adherence. If someone has stopped taking a statin because they read about side effects online, a one-on-one conversation about their personal risk and what the medication actually does for them is more useful than a printed reminder.
Collaborative practice agreements expand what pharmacists can do. Under these formal arrangements with prescribers, pharmacists can renew prescriptions, adjust medication therapy, and order lab tests. This reduces the friction of needing a separate doctor’s appointment just to continue or modify a medication.
Text message reminders are one of the simplest interventions and work across age and income groups. They’re particularly useful for unintentional non-adherence, where the main barrier is forgetting.
Mobile Apps and Digital Tools
Smartphone apps designed to support medication-taking have shown promising results. A systematic review of 14 randomized controlled trials found that all 14 reported improvements in adherence among app users, with 10 of those trials reaching statistical significance. These apps typically combine reminders, tracking features, and sometimes educational content about the condition being treated.
The studies ranged from 30 days to 12 months, with sample sizes between 57 and 412 participants. While the improvements were consistent, the size of the benefit varied depending on how adherence was measured. Apps appear to work best as one piece of a larger strategy rather than a standalone solution, particularly for people whose non-adherence is driven by beliefs about their medication rather than simple forgetfulness.